CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,410
- in 2 filings
Net −$5,410. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-17 | GARCIA PETER S Chief Financial Officer | Sale | −2,368 | $65.83 | $156K | 12,276 |
| 2021-08-17 | GARCIA PETER S Chief Financial Officer | Sale | −505 | $67.13 | $34K | 11,771 |
| 2021-08-17 | GARCIA PETER S Chief Financial Officer | Sale | −2,400 | $68.34 | $164K | 9,371 |
| 2021-08-17 | GARCIA PETER S Chief Financial Officer | Sale | −40 | $68.62 | $3K | 9,331 |
| 2021-08-17 | GARCIA PETER S Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −10,000 | 136,289 | ||
| 2021-08-10 | Randolph Sophia Chief Medical Officer | Sale | −1,718 | $64.20 | $110K | 169,871 |
| 2021-08-10 | Randolph Sophia Chief Medical Officer | Sale | −5,599 | $64.76 | $363K | 164,272 |
| 2021-08-10 | Randolph Sophia Chief Medical Officer | Sale | −70 | $65.46 | $5K | 164,202 |
| 2021-07-30 | Pinto Shelly VP, Finance and CAO | Grant or award · Employee Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-07-30 | Randolph Sophia Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2021-07-30 | GARCIA PETER S Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2021-07-30 | Pons Jaume President & CEO | Grant or award · Employee Stock Option (right to buy) | +225,000 | 225,000 | ||
| 2021-07-19 | Pons Jaume President & CEO | Sale | −1,300 | $53.62 | $70K | 509,946 |
| 2021-07-19 | Pons Jaume President & CEO | Sale | −9,500 | $54.37 | $517K | 500,446 |
| 2021-07-19 | Pons Jaume President & CEO | Sale | −5,900 | $55.08 | $325K | 494,546 |
| 2021-07-12 | Randolph Sophia Chief Medical Officer | Sale | −7,087 | $54.86 | $389K | 171,889 |
| 2021-07-12 | Randolph Sophia Chief Medical Officer | Sale | −300 | $55.86 | $17K | 171,589 |
| 2021-06-21 | Pons Jaume President & CEO | Sale | −6,347 | $58.06 | $369K | 521,599 |
| 2021-06-21 | Pons Jaume President & CEO | Sale | −10,353 | $58.92 | $610K | 511,246 |
| 2021-06-11 | Graham G. Walmsley Director | Grant or award · Stock option (right to buy) | +12,004 | 12,004 |
Page 15 of 22 · 432 trades